Evaluation of 17alpha-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands (Q44328387)

2 December 2017

Evaluation of 17alpha-E-(trifluoromethylphenyl)vinyl estradiols as novel estrogen receptor ligands (English)

1 reference

2 December 2017

Robert N Hanson

1

1 reference

2 December 2017

Choon Young Lee

2

1 reference

2 December 2017

Carolyn Friel

3

1 reference

2 December 2017

Alun Hughes

4

1 reference

2 December 2017

Eugene R DeSombre

5

1 reference

2 December 2017

1 February 2003

1 reference

2 December 2017

1 reference

2 December 2017

68

1 reference

2 December 2017

2

1 reference

2 December 2017

143-148

1 reference

2 December 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Selective oestrogen receptor modulation: molecular pharmacology for the millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]-phenyl]methanone hydrochloride (LY156758), a remarkably

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Structure-activity relationships of estrogenic ligands: synthesis and evaluation of (17 alpha, 20E)- and (17 alpha, 20Z)-21-halo-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Synthesis and estrogen receptor binding of (17 alpha, 20E)- and (17 alpha, 20Z)-21-phenylthio- and 21-phenylseleno-19-norpregna-1,3,5(10),20-tetraene-3,17 beta-diols

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Stereochemical probes for the estrogen receptor: synthesis and receptor binding of (17 alpha,20E/Z)-21-phenyl-19-norpregna-1,3,5(10), 20-tetraene-3,17 beta-diols

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Novel high-affinity steroidal estrogenic ligands: synthesis and receptor binding of 11 beta-vinyl-17 alpha-E/Z-phenylselenovinyl estradiols

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Synthesis and evaluation of 11beta-substituted 21-chloro/iodo-(17alpha,20E/Z)-19-norpregna-1,3,5(10),20-te traene-3, 17beta-diols: high-affinity ligands for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Comparative QSAR analysis of estrogen receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Effects of fluorine substitution on drug metabolism: pharmacological and toxicological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Metabolism of fluorine-containing drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Estrogen receptor binding affinity and uterotrophic activity of triphenylhaloethylenes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Comparative analyses of mechanistic differences among antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

Oestrogen receptor beta (ER beta).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900165-4

7 January 2021

10.1016/S0039-128X(02)00165-4

Identifiers

DOI

1 reference

2 December 2017

1 reference